About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Genetic Testing in Breast and Ovarian Cancer: BRCA1/2 and PARP Inhibitors
By
Holy Cross 9th Annual Winter Oncology Symposium
FEATURING
Delia Constanza Guaqueta
By
Holy Cross 9th Annual Winter Oncology Symposium
FEATURING
Delia Constanza Guaqueta
0 views
March 20, 2019
Comments
0
Login to view comments.
Click here to Login
Featured Video
11:42
ImmunoGen
Best Practices for the management of ocular adverse events associate…
Feat.
K. Lamoreau
Featured Video
17:33
AstraZeneca Oncology
First-line Maintenance Therapy for BRCAm Advanced Ovarian Cancer Fol…
Feat.
S. Lewin
Recommended
AUTOPLAY
ON
Related
Newest
25:08
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice
Feat.
S. Tolaney,
H. Rugo
12:35
Insights from 2023 SABCS
SABCS 2023 Summary: "What Is the Appropriate 1L Therapy for ER+…
Feat.
S. Tolaney,
H. Rugo
07:23
Total Health
Advanced Stage HR+ BC: Fine-Tuning Sequential Endocrine and Targeted…
Feat.
R. O'Regan
09:19
Insights from 2023 SABCS
SABCS 2023 Insights: "Biology or Stage? Tailoring Treatment for…
Feat.
K. Kalinsky
09:55
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future H…
Feat.
E. Hamilton
09:06
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Gynecologic Oncology Updates"
Feat.
R. Salani
14:45
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Gynecological Cancers Highlights"
Feat.
M. Raza Mirza
36:18
Insights from ESMO Breast 2024 Annual Meeting
Metastatic Breast Cancer Comprehensive Review: ESMO Breast 2024 Awar…
Feat.
H. Rugo
06:10
Insights from ESMO Breast 2024 Annual Meeting
ESMO Breast 2024 Summary: "Is There a Role for Combining ADCs W…
Feat.
S. Tolaney
49:07
SABCS 2022 Conference Coverage
SABCS 2022 Expert Panel Discussion: Practice-Changing Updates
Feat.
J. O'Shaughnessy,
S. Tolaney,
S. Hurvitz,
H. Rugo
07:50
Oncology Data Advisor
ESMO 2023 Insights: "Real-World Use Patterns, Effectiveness, &a…
Feat.
K. Kalinsky
33:44
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Expert Recap: "Metastatic Breast Cancer Deep Dive &a…
Feat.
S. Tolaney,
H. Rugo
17:35
Insights from 2023 SABCS
SABCS 2023 Summary: "Top 5 Studies Including KATHERINE & HE…
Feat.
P. Tarantino
10:09
Insights from ESMO Breast 2024 Annual Meeting
ESMO Breast 2024 Insights: "Pooled Analysis of T-DXd Retreatmen…
Feat.
H. Rugo
05:35
Insights from ESMO Breast 2024 Annual Meeting
ESMO Breast 2024 Insights: "IMpassion132 Trial - Is There a Rol…
Feat.
S. Tolaney
25:35
Total Health
NGS and Liquid Biopsy: Overcoming Challenges in Widespread Testing
Feat.
S. Kazmi
16:57
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…
Feat.
V. Subbiah
21:37
Dana-Farber Cancer Institute
Standard Treatments for HR+/HER2- mBC in 2023
Feat.
S. Sammons
09:26
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "DESTINY-Breast06 - T-DXd vs. Physician’s …
Feat.
G. Curigliano
06:07
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Summary: "Key Updates in Gynecological Cancers"
Feat.
M. Raza Mirza
